The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Zalevsky Jonathan since year 2005.
The trader's CIK number is 1789857.
At the time of the last reporting, Zalevsky Jonathan was the Chief R&D Officer of Nektar Therapeutics .
(stock ticker symbol NKTR).
See this page for all insider trading activities at Nektar Therapeutics .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zalevsky Jonathan (Chief R&D Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.